Organigram Holdings Inc. buy krebskrebs
Start price
25.01.21
/
50%
€5.88
Target price
25.01.22
€16.00
Performance (%)
-15.72%
End price
26.01.22
€4.95
Summary
This prediction ended on 26.01.22 with a price of €4.95. The prediction for Organigram Holdings Inc. disappointed with a performance of -15.72%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Organigram Holdings Inc. | -5.357% | -5.357% | -10.382% | -82.082% |
iShares Core DAX® | 2.149% | 5.415% | 21.385% | 22.595% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% | 55.330% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% | 9.481% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% | 49.646% |
Comments by krebskrebs for this prediction
In the thread Organigram Holdings Inc. diskutieren
Buy mit Kursziel 4,0
In the thread Trading Organigram Holdings Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten